Patents by Inventor Rene Coffeng

Rene Coffeng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230301531
    Abstract: An apparatus comprising a monitor, a blood pressure measuring device, and a controller. The monitor is configured to estimate a blood pressure of a patient. The blood pressure measuring device is configured to measure a blood pressure of the patient. The controller is operatively coupled to the monitor and to the blood pressure measuring device. The controller is configured to cause the blood pressure measuring device to take a first blood pressure measurement of the patient in response to an estimated blood pressure deviating from a baseline. The controller is also configured to cause the blood pressure measuring device to take a second blood pressure measurement of the patient in response to an estimated blood pressure deviating from a second baseline different than the first baseline.
    Type: Application
    Filed: March 25, 2022
    Publication date: September 28, 2023
    Inventors: Juha Virtanen, René Coffeng, Panu Takala, Emma Hellman
  • Publication number: 20230140973
    Abstract: A system for measuring ECG data and respiratory data for a patient. The system includes at least four ECG wires configured to communicate a first set of cardiac electrical activity from the patient. A respiratory wire distinct from the at least four ECG wires is configured to communicate respiratory electrical activity from the patient. An electronics device is electrically coupled to the at least four ECG wires and to the respiratory wire. The electronics device is configured to measure the ECG data based on the first set of cardiac electrical activity from the at least four ECG wires, and to measure the respiratory data based on the respiratory electrical activity from the respiratory wire.
    Type: Application
    Filed: November 10, 2021
    Publication date: May 11, 2023
    Applicant: GE Precision Healthcare LLC
    Inventors: Juha Virtanen, Emma Hellman, René Coffeng, Terho Pulliainen
  • Publication number: 20220400967
    Abstract: A method of measuring noninvasive blood pressure includes determining a window for pulse detection for a patient, receiving a pressure signal measured from a measure sensor in a blood pressure cuff, and setting a pulse detection period for each heart beat based on the window and a heart beat indicator indicating at least one heart beat time for the patient. The pressure signal is then examined within each pulse detection period to identify a pressure peak therein. A blood pressure for the patient is determined based on the pressure peaks detected in the pressure signal.
    Type: Application
    Filed: June 21, 2021
    Publication date: December 22, 2022
    Applicant: GE Precision Healthcare LLC
    Inventor: Rene Coffeng
  • Patent number: 9101335
    Abstract: A method, device, and computer program product for managing alarms during a care process are disclosed. Care is provided to a subject according to settings of at least one care device and physiological parameters obtained from the subject are monitored, wherein the monitoring comprises triggering an alarm in response to detection of an alarm event. To enable smooth transfer from an alarm event to normal monitoring state, at least one available control option is determined for recovering from the alarm event. A user is prompted to select one of the at least one available control option, thereby to obtain a user-selected control option and the settings of the at least one care device are adjusted according to the user-selected control option.
    Type: Grant
    Filed: June 20, 2011
    Date of Patent: August 11, 2015
    Assignee: General Electric Company
    Inventor: Rene Coffeng
  • Patent number: 8985107
    Abstract: A method, device, and computer program product for improving accuracy of a respiratory gas measurement from a subject ventilated at a predetermined respiration rate through a ventilator. A respiratory gas measurement value is acquired within a first expiration period of the subject, thereby to obtain a first measurement value. The ventilator is paused for a pause period within a second expiration period of the subject and a respiratory gas measurement is performed within the pause period, thereby to obtain a second measurement value. A correction factor is then determined based on the first measurement value and the second measurement value and the correction factor is employed to correct subsequent respiratory gas measurement values obtained from the subject at the predetermined respiration rate, thereby to improve the accuracy of the measurement.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: March 24, 2015
    Assignee: General Electric Company
    Inventors: Hanna Viertiö-Oja, Rene Coffeng
  • Publication number: 20140032241
    Abstract: A method, device, and computer program product for monitoring clinical state of a subject are disclosed. To facilitate the manual adaptation of the care processes to the current state of a patient at least one input parameter is retrieved, wherein each input parameter is indicative of control applied to a respective physiological process of the subject. An output parameter is acquired for each of the at least one input parameter, thereby to obtain a parameter pair, wherein each input and output parameter is indicative of the respective physiological process. Each parameter pair is presented on a dedicated two-dimensional plot comprising a first axis representing respective input parameter and a second axis representing, respective output parameter, wherein the first axis is scaled according to the input operating range of the respective input parameter and the second axis is scaled according to the output operating range of the respective output parameter.
    Type: Application
    Filed: July 26, 2012
    Publication date: January 30, 2014
    Applicant: General Electric Company
    Inventor: Rene Coffeng
  • Publication number: 20130220323
    Abstract: A method, device, and computer program product for improving accuracy of a respiratory gas measurement from a subject ventilated at a predetermined respiration rate through a ventilator. A respiratory gas measurement value is acquired within a first expiration period of the subject, thereby to obtain a first measurement value. The ventilator is paused for a pause period within a second expiration period of the subject and a respiratory gas measurement is performed within the pause period, thereby to obtain a second measurement value. A correction factor is then determined based on the first measurement value and the second measurement value and the correction factor is employed to correct subsequent respiratory gas measurement values obtained from the subject at the predetermined respiration rate, thereby to improve the accuracy of the measurement.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 29, 2013
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Hanna Viertiö-Oja, Rene Coffeng
  • Patent number: 8479731
    Abstract: A method and apparatus for determining the presence or absence of a pulmonary embolism (PE) in a patient. The breathing gas CO2 partial pressure (PCO2) during the expiration of breathing gases by the patient, the end tidal (EtCO2), CO2 partial pressure, and the CO2 partial pressure (PaCO2) of the blood are measured. The volume (V) of breathing gases expired during the expiration of breathing gases by the patient is also measured and a relationship between changes in breathing gas CO2 partial pressure (PCO2) and changes in breathing gas volume (V) in an alveolar expiration phase of patient expiration is determined. The difference between the blood CO2 partial pressure (PaCO2) and the end expiration CO2 partial pressure is divided by the relationship between PCO2 and V produce a quantity which is compared to a threshold value. If the quantity is below the threshold value, the absence of a pulmonary embolism is indicated.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: July 9, 2013
    Assignee: General Electric Company
    Inventors: Erkki Heinonen, Rene Coffeng, Franck Verschuren
  • Publication number: 20120319848
    Abstract: A method, device, and computer program product for managing alarms during a care process are disclosed. Care is provided to a subject according to settings of at least one care device and physiological parameters obtained from the subject are monitored, wherein the monitoring comprises triggering an alarm in response to detection of an alarm event. To enable smooth transfer from an alarm event to normal monitoring state, at least one available control option is determined for recovering from the alarm event. A user is prompted to select one of the at least one available control option, thereby to obtain a user-selected control option and the settings of the at least one care device are adjusted according to the user-selected control option.
    Type: Application
    Filed: June 20, 2011
    Publication date: December 20, 2012
    Applicant: General Electric Company
    Inventor: Rene Coffeng
  • Patent number: 7997269
    Abstract: The system and method includes a treatment device such as an anesthetic machine or IV, a monitor and a display configured to display real-time PK/PD data associated with an anesthetic agent administered to the patient. The system and method further includes a safety control means configured to control the display such that one of a basic display state, an interactive effects display state, and a display inhibited state is selected and displayed according to the anesthetic agents and levels of the same being administered to the patient.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: August 16, 2011
    Assignee: General Electric Company
    Inventors: Laurence Yudkovitch, Ronald P. Makin, René Coffeng, Michael Mitton
  • Publication number: 20100169063
    Abstract: A system and method of modeling the pharmacodynamic effect of drugs delivered to a patient. The system includes a model database comprising a first drug interaction model and a second drug interaction model. A processing unit determines a first pharmacodynamic effect and a second pharmacodynamic effect and using a dominance rule to compare the first pharmacodynamic effect and a second pharmacodynamic effect to determine a dominant interaction model. A graphical display connected to the processing unit presents the determined dominant interaction model.
    Type: Application
    Filed: December 31, 2008
    Publication date: July 1, 2010
    Applicant: The General Electric Company
    Inventors: Laurence M. Yudkovitch, Ronald P. Makin, Rene Coffeng, Michael D. Krajnak
  • Publication number: 20080097166
    Abstract: The system and method includes a treatment device such as an anesthetic machine or IV, a monitor and a display configured to display real-time PK/PD data associated with an anesthetic agent administered to the patient. The system and method further includes a safety control means configured to control the display such that one of a basic display state, an interactive effects display state, and a display inhibited state is selected and displayed according to the anesthetic agents and levels of the same being administered to the patient.
    Type: Application
    Filed: January 4, 2007
    Publication date: April 24, 2008
    Inventors: Laurence Yudkovitch, Ronald P. Makin, Rene Coffeng, Michael Mitton
  • Publication number: 20080091084
    Abstract: A graphical user interface for use by a clinician in the monitoring of the depth of the anesthesia of a patient. The graphical user interface comprising a drug library with data related to a plurality of anesthetic drugs, a drug administration window for displaying drug administration data, at least one window disposed for the display of a pharmacokinetic graph and a pharmacodynamic graph, and a scale selector comprising a first condition wherein the pharmacokinetic model and the pharmacodynamic models are displayed and a second condition where only the pharmacokinetic model is displayed.
    Type: Application
    Filed: November 28, 2006
    Publication date: April 17, 2008
    Inventors: Laurence M. Yudkovitch, Ronald P. Makin, Rene Coffeng, Toni Taiminen, Tom J. Haggblom, Jussi Heikkola
  • Publication number: 20080091083
    Abstract: A graphical user interface for the documentation of an administered anesthetic drug and the display of an associated pharmacokinetic model and an associated pharmacodynamic model. The graphical user interface comprises a first window that displays the drug administration data, and a second window displaying a pharmacokinetic model and a pharmacodynamic model, the second window being separate and distinct from the first window. The pharmacokinetic model and the pharmacodynamic models are overlaid and displayed and the pharmacokinetic model and the pharmacodynamic model are based on the drug administration data displayed in the first window.
    Type: Application
    Filed: November 28, 2006
    Publication date: April 17, 2008
    Inventors: Laurence M. Yudkovitch, Ronald P. Makin, Rene Coffeng
  • Publication number: 20070129646
    Abstract: A method and apparatus for determining the presence or absence of a pulmonary embolism (PE) in a patient. The breathing gas CO2 partial pressure (PCO2) during the expiration of breathing gases by the patient, the end tidal (EtCO2), CO2 partial pressure, and the CO2 partial pressure (PaCO2) of the blood are measured. The volume (V) of breathing gases expired during the expiration of breathing gases by the patient is also measured and a relationship between changes in breathing gas CO2 partial pressure (PCO2) and changes in breathing gas volume (V) in an alveolar expiration phase of patient expiration is determined. The difference between the blood CO2 partial pressure (PaCO2) and the end expiration CO2 partial pressure is divided by the relationship between PCO2 and V produce a quantity which is compared to a threshold value. If the quantity is below the threshold value, the absence of a pulmonary embolism is indicated.
    Type: Application
    Filed: December 2, 2005
    Publication date: June 7, 2007
    Inventors: Erkki Heinonen, Rene Coffeng, Franck Verschuren